Erste Asset Management’s BioNTech BNTX Stock Holding History

Erste Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.5M	Hold	47,700	–	–	0.04%	301
2026 Q1	$4.07M	Hold	47,700	–	–	0.04%	290
2025 Q4	$4.54M	Hold	47,700	–	–	0.04%	283
2025 Q3	$4.68M	Hold	47,700	–	–	0.05%	261
2025 Q2	$5.09M	Buy	47,700 +5,700	+14%	+$576K	0.04%	271
2025 Q1	$3.99M	Buy	+42,000	New	+$4.7M	0.05%	245
2022 Q1	–	Sell	-5,500	Closed	-$1.33M	–	557
2021 Q4	$1.33M	Hold	5,500	–	–	0.02%	331
2021 Q3	$1.52M	Sell	5,500 -9,500	-63%	-$3.02M	0.03%	299
2021 Q2	$3.43M	Hold	15,000	–	–	0.07%	249
2021 Q1	$1.44M	Hold	15,000	–	–	0.04%	308
2020 Q4	$1.32M	Hold	15,000	–	–	0.04%	310
2020 Q3	$998K	Buy	+15,000	New	+$1.08M	0.03%	300

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Erste Asset Management's BNTX Position: Q2 2026 in Review

Erste Asset Management held its BioNTech (BNTX) position steady in Q2 2026 at 47,700 shares worth $4.5M. The position accounts for 0.04% of the portfolio, ranked #301.

Erste Asset Management first reported a position in BNTX in Q3 2020 and has held it in 12 quarters since. The position peaked at $5.09M in Q2 2025. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Erste Asset Management held 47,700 shares of BioNTech worth $4.5M as of Q2 2026.
Erste Asset Management left its BioNTech share count unchanged in Q2 2026.
BioNTech made up 0.04% of Erste Asset Management's portfolio in Q2 2026, its #301 holding.
Erste Asset Management first reported a position in BioNTech in Q3 2020 and has held it in 12 quarters since.
Erste Asset Management's BioNTech position peaked at $5.09M in Q2 2025.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.